Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2012-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.00390.2012PMID 22961865PMCID PMC3517638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*

  2012cited by this paper
• Role of selective V1a receptor agonism in ovine septic shock*

  2011cited by this paper
• Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis

  2011cited by this paper
• Endothelial activation, dysfunction and permeability during severe infections

  2011cited by this paper
• Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*

  2011cited by this paper
• New, potent, selective, and short-acting peptidic V1a receptor agonists.

  2011cited by this paper
• Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?

  2011cited by this paper
• Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model

  2010cited by this paper
• Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study

  2010cited by this paper
• Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock

  2009cited by this paper
• CARDIOVASCULAR COLLAPSE AND VASCULAR PERMEABILITY CHANGES IN AN OVINE MODEL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SEPSIS

  2009cited by this paper
• Molecular mechanisms of endothelial hyperpermeability: implications in inflammation

  2009cited by this paper
• Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury*

  2009cited by this paper
• Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

  2009cited by this paper
• Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial

  2009cited by this paper
• Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial

  2009cited by this paper
• The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness

  2009cited by this paper
• The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008.

  2008cited by this paper
• Epinephrine: what place in sepsis?

  2008cited by this paper
• Angiopoietin-2, Marker and Mediator of Endothelial Activation With Prognostic Significance Early After Trauma?

  2008cited by this paper
• Vasopressin versus norepinephrine infusion in patients with septic shock.

  2008cited by this paper
• Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients

  2008cited by this paper
• Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients

  2008cited by this paper
• Vasopressin: useful or not?

  2008cited by this paper
• Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep

  2008cited by this paper
• Vasopressin: Mechanisms of action on the vasculature in health and in septic shock

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• NOVEL OVINE MODEL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS-INDUCED PNEUMONIA AND SEPSIS

  2007cited by this paper
• Angiopoietin‐2 is increased in severe sepsis: Correlation with inflammatory mediators

  2007cited by this paper
• Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock

  2006cited by this paper
• Management of sepsis.

  2006cited by this paper
• Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality

  2006cited by this paper
• The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease.

  2006cited by this paper
• Arginine vasopressin in 316 patients with advanced vasodilatory shock*

  2005cited by this paper
• Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers.

  2005cited by this paper
• VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED DURING THE FIRST 48 HOURS OF HUMAN SEPTIC SHOCK AND CORRELATES WITH VASCULAR PERMEABILITY

  2005cited by this paper
• Microvascular dysfunction as a cause of organ dysfunction in severe sepsis

  2005cited by this paper
• Dopexamine Reverses the Vasopressin-Associated Impairment in Tissue Oxygen Supply but Decreases Systemic Blood Pressure in Ovine Endotoxemia

  2004cited by this paper
• The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.

  2004cited by this paper
• Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor‐ and cAMP‐mediated signaling

  2003cited by this paper
• Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

  2003cited by this paper
• Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study

  2003cited by this paper
• Airway obstruction in sheep with burn and smoke inhalation injuries.

  2003cited by this paper
• Low-dose vasopressin in the treatment of septic shock in sheep.

  2003cited by this paper
• Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock

  2002cited by this paper
• Pre- and Postnatal Lung Development, Maturation, and Plasticity Increased expansion of the lung stimulates calmodulin 2 expression in fetal sheep

  2002cited by this paper
• Angiopoietin-1 protects the adult vasculature against plasma leakage

  2000cited by this paper
• Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.

  2000cited by this paper
• [Arg8]-vasopressin-induced increase in intracellular Ca2+ concentration in cultured rat hippocampal neurons.

  1999cited by this paper
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules.

  1995cited by this paper
• 74; ENDOTHELIN‐1 mRNA EXPRESSION IN THE SMALL INTESTINE DURING PERITONITIS

  1994cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Measurement of Pulmonary Edema

  1965cited by this paper
• Vasopressin analogues with selective pressor activity

  1964cited by this paper

• THE EFFECT OF CATECHOLAMINE VERSUS NONCATECHOLAMINE VASOPRESSORS ON RENAL FUNCTION AND RECOVERY IN VASODILATORY SHOCK: A SYSTEMATIC REVIEW OF PRECLINICAL AND CLINICAL STUDIES

  2024cites this paper
• Vascular leak in sepsis: physiological basis and potential therapeutic advances

  2024cites this paper
• Acute Hemodynamics in the Fontan Circulation: Open-Label Study of Vasopressin*

  2023cites this paper
• The effect of fluid therapy during the first 12 hours after septic shock onset in pediatric patients

  2023cites this paper
• Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review

  2022cites this paper
• Pathophysiology, mechanisms, and managements of tissue hypoxia.

  2022cites this paper
• Alternatives to norepinephrine in septic shock: Which agents and when?

  2022cites this paper
• Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO

  2021cites this paper
• Endothelial dysfunction: a therapeutic target in bacterial sepsis?

  2021cites this paper
• Fluid resuscitation in sepsis: the great 30 mL per kg hoax.

  2020cites this paper
• New Agents in Development for Sepsis: Any Reason for Hope?

  2020cites this paper
• Selepressin for Patients With Septic Shock.

  2020cites this paper
• ARGININE VASOPRESSIN RECEPTOR 2 ACTIVATION PROMOTES MICROVASCULAR PERMEABILITY IN SEPSIS.

  2020influential citation
• Vasopressor Therapy in the Intensive Care Unit

  2020cites this paper
• Vasopressors to treat refractory septic shock: a narrative review.

  2020cites this paper
• Safety and efficacy of vasopressin following Fontan completion: A randomized pilot study.

  2019cites this paper
• Shock – Classification and Pathophysiological Principles of Therapeutics

  2019cites this paper
• Pharmacology of Cardiovascular Drugs

  2019cites this paper
• Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.

  2019cites this paper
• Surviving Sepsis Campaign Guidelines: evolution of early goal-directed therapy

  2018influential citation
• Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.

  2018cites this paper
• 1404: AN EICU/ICU COLLABORATIVE TO REDUCE SEPSIS MORTALITY

  2018cites this paper
• Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

  2017cites this paper
• Vasopressin, Norepinephrine, and Vasodilatory Shock after Cardiac Surgery: Another "VASST" Difference?

  2017cites this paper
• Neuroendocrine Derangements in Early Septic Shock: Pharmacotherapy for Relative Adrenal and Vasopressin Insufficiency

  2017cites this paper
• Early and sustained vasopressin infusion augments the hemodynamic efficacy of restrictive fluid resuscitation and improves survival in a liver laceration model of hemorrhagic shock

  2017cites this paper
• Pharmacologic studies on ET‐26 hydrochloride in a rat model of lipopolysaccharide‐induced sepsis

  2017cites this paper
• Fluid Resuscitation in Sepsis: "Get the Balance Right".

  2017cites this paper
• Physician Culture and Vasopressin Use in Septic Shock.

  2016cites this paper
• Effect of non-adrenergic vasopressors on macro- and microvascular coupling in distributive shock.

  2016cites this paper
• Adjunctive treatment in septic shock: What's next?

  2016cites this paper
• Vasopressin After the Fontan Operation

  2016cites this paper
• A rational approach to fluid therapy in sepsis.

  2016cites this paper
• A rational approach to fl uid therapy in sepsis

  2015cites this paper
• A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*

  2015influential citation
• Early management of severe sepsis: concepts and controversies.

  2014cites this paper
• Selepressin in septic shock: sharpening the VASST effects of vasopressin?*.

  2014cites this paper
• The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*

  2014cites this paper
• HMGB1 as a drug target in staphylococcal pneumonia

  2014cites this paper
• Iatrogenic salt water drowning and the hazards of a high central venous pressure

  2014influential citation
• Vasopresseurs et choc septique

  2014cites this paper
• Possible variables related to paradoxical findings between PCR and hemoculture assays in rat experimental sepsis

  2013cites this paper
• Receptor-selective vasopressin analogs: a new push for "decatecholaminization"?

  2013cites this paper
• Vasopressin und Terlipressin beim vasodilatatorischen Schock

  2012cites this paper
• Vasopresseurs et choc septique Vasopressors and septic shock

  year unknowncites this paper